in billion, additional I the as Adjusted prior will quarter performance EBITDA $X.XX for good the for Sam, comments you, and the $X.XX morning, billion quarter. on Thank everyone. year. provide was Great. some compared our to
claims noted our related to in commercial that revenues in certain quarter year, recorded of disputed increase of this a in resolving period. $XXX a an million six-year the As with release, first we payer covered
$XXX admissions an Texas year we directed relates million X% as admissions also revenues of related it XXXX. the X.X% experiencing to to about quarter prior we year, that to additional for will still COVID the prior first year of of this earlier high comparisons, and level of the last expenses of In were volumes million compared note, payment in $XX an I quarter, for recorded COVID year. accounted program period.
care this quarter, in with In versus the year. quarter. about was volume Sam prior year and mix payments managed and approximately the admissions trends. quarter highlighted the year's the prior when support other year case COVID-related non-COVID good admissions of our versus and managed in this compared during X.X% payer addition, grew recognized care prior to facility grew and the coupled first XX.X% in $XX Same quarter, positive we million million mix $XXX metrics
both improved remain to as year and quarter of management operating team's higher fourth of to inpatient our with quarter. our pleased Non-COVID first contributed increasing admission with the year. X%, backdrop the as of prior under X.X%, from case last compared just compared per inflation. This cost non-COVID mix to even the sequentially revenue We
a our XX.X% year favorably improved as trend costs was to compared and quarter. Our revenue sequentially the supply in adjusted when of to continue Labor both as consolidated percentage EBITDA and well. prior the margin cost
have compared have percentage approximately pressures previously points increased subject a basis some We as cost the and prior when discussed been revenue, XX expenses year. other of to operating inflationary to
me key our let allocation and strategies. some growth they to So creation value cash a of flow capital and long-term speak metrics as part remain
billion operations the from $X.X $XXX this in the year increased to billion $X.XX million year. in from quarter prior flow cash Our
paid just $XXX million $XXX stock billion. under in Capital We of spending quarter. under and just the was during dividends repurchased $X.X our million
range EBITDA debt-to-adjusted times X ratio to leverage leverage near times. stated of end low our remains Our X the of
guidance follows. our As noted as updating morning, full-year are this our release in we XXXX
$XX.X and billion. billion $XX.X between range to revenues expect We
between HCA income billion. net attributable $X.XX range expect and We Healthcare to $X.XX to billion
expect billion $X.X adjusted EBITDA $XX.X year. range to to lastly, capital and spending And during between full-year and the earnings billion expect share We we $XX.X $XX.XX. billion. range approximate we to diluted $XX.XX full-year per And between expect
will that capital continue on we considers updated is invest agenda, planning acquisitions to future to it development. we based some I growth land for guidance mention also are spending exist believe and our opportunities
In addition, we are construction factored in costs some seeing well. our have inflationary as we that guidance increases into
ownership Finally, I Valesco will with our mention, in a on the venture transaction increase in Envision. early we closed April, to joint interest
this and consolidate EBITDA. adjusted the will second no material the venture, approximately annual with will revenues to generate in expect We of venture $X impact billion beginning quarter
we'll Q&A. We your look up over for to forward and questions. open it So with to that, I'll turn the call Frank,